Real-world data on adjuvant capecitabine after standard neoadjuvant chemotherapy for triple negative breast cancer (2024)
- Authors:
- USP affiliated authors: TIEZZI, DANIEL GUIMARÃES - FMRP ; CARRARA, HELIO HUMBERTO ANGOTTI - FMRP ; ANDRADE, JURANDYR MOREIRA DE - FMRP ; BUZATTO, ISABELA PANZERI CARLOTTI - FMRP ; BUONO, FABIANA DE OLIVEIRA - FMRP
- Unidade: FMRP
- DOI: 10.61622/rbgo/2024rbgo29
- Subjects: NEOPLASIAS MAMÁRIAS; LINFONODOS; RESULTADO DE TRATAMENTO; FÁRMACOS IMUNOSSUPRESSORES
- Keywords: Breast neoplasms; Neoadjuvant therapy; Triple-negative breast neoplasms; Capecitabine/therapeutic use
- Agências de fomento:
- Language: Inglês
- Imprenta:
- Publisher place: Rio de Janeiro
- Date published: 2024
- Source:
- Título: Revista Brasileira de Ginecologia e Obstetrícia
- ISSN: 0100-7203
- Volume/Número/Paginação/Ano: v. 46, art. e-rbgo29, [6] p., 2024
- Este periódico é de acesso aberto
- Este artigo NÃO é de acesso aberto
-
ABNT
PEREIRA, Maria Fernanda Mendonça et al. Real-world data on adjuvant capecitabine after standard neoadjuvant chemotherapy for triple negative breast cancer. Revista Brasileira de Ginecologia e Obstetrícia, v. 46, p. [6] , 2024Tradução . . Disponível em: https://doi.org/10.61622/rbgo/2024rbgo29. Acesso em: 26 jan. 2026. -
APA
Pereira, M. F. M., Buzatto, I. P. C., Carrara, H. H. A., Buono, F. de O., Andrade, J. M. de, Orlandini, L. F., & Tiezzi, D. G. (2024). Real-world data on adjuvant capecitabine after standard neoadjuvant chemotherapy for triple negative breast cancer. Revista Brasileira de Ginecologia e Obstetrícia, 46, [6] . doi:10.61622/rbgo/2024rbgo29 -
NLM
Pereira MFM, Buzatto IPC, Carrara HHA, Buono F de O, Andrade JM de, Orlandini LF, Tiezzi DG. Real-world data on adjuvant capecitabine after standard neoadjuvant chemotherapy for triple negative breast cancer [Internet]. Revista Brasileira de Ginecologia e Obstetrícia. 2024 ; 46 [6] .[citado 2026 jan. 26 ] Available from: https://doi.org/10.61622/rbgo/2024rbgo29 -
Vancouver
Pereira MFM, Buzatto IPC, Carrara HHA, Buono F de O, Andrade JM de, Orlandini LF, Tiezzi DG. Real-world data on adjuvant capecitabine after standard neoadjuvant chemotherapy for triple negative breast cancer [Internet]. Revista Brasileira de Ginecologia e Obstetrícia. 2024 ; 46 [6] .[citado 2026 jan. 26 ] Available from: https://doi.org/10.61622/rbgo/2024rbgo29 - Quality of life in women with breast cancer treated with or without chemotherapy
- Molecular/genomic profile enhances prediction of response to target therapy in HER2-positive breast cancer
- Potential biomarkers as a predictive factor of response to primary chemotherapy in breast cancer patients
- Cancer stem cells and lymph node metastasis in early stage breast cancer
- Trastuzumab use during pregnancy: long-term survival after locally advanced breast cancer and long-term infant follow-up
- Idade como fator independente de prognóstico no câncer de mama
- Neoadjuvant chemotherapy with trastuzumab in HER2-positive breast cancer: pathologic complete response rate, predictive and prognostic factors
- Clinicopathological characteristics and recurrence risk in patients with ductal carcinoma in situ of the breast
- Taxane-based chemotherapy enhances response to neoadjuvant treatment for stage II and III breast cancer
- Expression of hypoxia-inducible factor 1-'alfa' and vascular endothelial growth factor-C in locally advanced breast cancer patients
Informações sobre o DOI: 10.61622/rbgo/2024rbgo29 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
